Abiopharma

News list

Director ABALLI JOHN 🔴 sold 11.4K shares of EXAGEN INC. (XGN) at $3.61 Transaction Date: Feb 24, 2026 | Filing ID: 000002

Full text

News bot Feb. 26, 2026, 12:12 a.m.
🔍 ABALLI JOHN (Director)

Company: EXAGEN INC. (XGN)

Report Date: 2026-02-24
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares sold: 11,430
- Total shares held: 40,401
Detailed Transactions and Holdings:
- Sold 11,430 shares of Common Stock at $3.61 per share (Direct)
  Date: 2026-02-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 702,997.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-02-24 | Code: H | nature_of_ownership: by Spouse | shares_owned_after: 40,401.00
Footnotes:
- F1: The sale reported on this Form 4 represents shares sold by the Reporting Person, at the direction of the Issuer, to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated solely by the Issuer and does not represent a discretionary transaction by the Reporting Person.